ASBP (Aspire-Lakewood Holdings) OCF Margin %: -3,358.73% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASBP Aspire-Lakewood Holdings Inc ASBP
11 GF Score
Price $9.25
! 2 Warning Signs
View Full Analysis

What is Aspire-Lakewood Holdings OCF Margin %?

Aspire-Lakewood Holdings ASBP +2.42% 11 OCF Margin % is -3,358.73% as of Jun. 2026. GuruFocus rates ASBP with a GF Score™ of 11/100. The stock has 2 warning signs investors should review. Among 961 Biotechnology companies, Aspire-Lakewood Holdings ranks worse than 92.92% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Aspire-Lakewood Holdings's Cash Flow from Operations for the three months ended in Jun. 2026 was $-2.12 Mil. Aspire-Lakewood Holdings's Revenue for the three months ended in Jun. 2026 was $0.06 Mil. Therefore, Aspire-Lakewood Holdings's OCF Margin % for the quarter that ended in Jun. 2026 was -3,358.73%.

As of today, Aspire-Lakewood Holdings's current OCF Yield % is -56.20%.

The historical rank and industry rank for Aspire-Lakewood Holdings's OCF Margin % or its related term are showing as below:

ASBP' s OCF Margin % Range Over the Past 10 Years
Min: -82050   Med: -82050   Max: -82050
Current: -7409.28

During the past 4 years, the highest OCF Margin % of Aspire-Lakewood Holdings was -82050.00%. The lowest was -82050.00%. And the median was -82050.00%.

ASBP's OCF Margin % is ranked worse than
92.92% of 961 companies
in the Biotechnology industry
Industry Median: -67.62 vs ASBP: -7409.28

Aspire-Lakewood Holdings OCF Margin % Related Terms

Aspire-Lakewood Holdings OCF Margin % Historical Data

* Premium members only.

The historical data trend for Aspire-Lakewood Holdings's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspire-Lakewood Holdings OCF Margin % Chart

Aspire-Lakewood Holdings Annual Data
Trend Dec22 Dec23 Dec24 Dec25
OCF Margin %
0.00 0.00 0.00 -82,050.00

Aspire-Lakewood Holdings Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -55,200.00 -23,200.00 -10,853.57 -3,358.73

ASBP vs PDSB, KPRX, SNTI: OCF Margin % Comparison

For the Biotechnology subindustry, Aspire-Lakewood Holdings's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aspire-Lakewood Holdings OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aspire-Lakewood Holdings's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Aspire-Lakewood Holdings's OCF Margin % falls into.


ASBP
11GF Score
Aspire-Lakewood Holdings Inc ASBP
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspire-Lakewood Holdings OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Aspire-Lakewood Holdings's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-4.923/0.006
=-82,050.00 %

Aspire-Lakewood Holdings's OCF Margin for the quarter that ended in Jun. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=-2.116/0.063
=-3,358.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -3,358.73% mean?
Aspire-Lakewood Holdings (ASBP) has a OCF Margin % of -3,358.73% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Aspire-Lakewood Holdings and its competitors. According to the industry distribution chart, Aspire-Lakewood Holdings ranks #893 out of 961 companies in the Biotechnology industry, placing it in the top 92.9%.
Is Aspire-Lakewood Holdings' OCF Margin % too high?
Aspire-Lakewood Holdings' current OCF Margin % is -3,358.73%. Based on the distribution chart, Aspire-Lakewood Holdings ranks #893 out of 961 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Aspire-Lakewood Holdings has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Aspire-Lakewood Holdings' OCF Margin % compare to PDSB and KPRX?
According to the Biotechnology industry distribution chart, Aspire-Lakewood Holdings ranks #893 out of 961 companies for OCF Margin %. This places Aspire-Lakewood Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Aspire-Lakewood Holdings and its competitors. Aspire-Lakewood Holdings's current OCF Margin % is -3,358.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspire-Lakewood Holdings stock overvalued right now?
Aspire-Lakewood Holdings (ASBP) has a current OCF Margin % of -3,358.73%. The current OCF Margin % is -3,358.73%. Aspire-Lakewood Holdings' overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Aspire-Lakewood Holdings (ASBP), the current OCF Margin % is -3,358.73% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aspire-Lakewood Holdings Business Description

Address 23150 Fashion Drive, Suite 232, Estero, FL, USA, 33928
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
11GF Score

Get the complete analysis for ASBP

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.25
Price